“…Exclusion of secondary hypertension, including endocrine hypertension (mainly primary aldosteronism, but also pheochromocytoma and hypercortisolism) is recommended in these patients. Therefore the patients are switched to a drug combination of alpha 1 adrenoreceptor antagonists (A1AAs) [2,3] and/or calcium channel blockers (CCBs) [4][5][6], which does not affect plasma concentration of the endogenous hormones connected to secondary hypertension. Doxazosin and verapamil ( Fig.…”